Humoral and cellular immune responses eleven months after the third dose of BNT162b2 an mRNA-based COVID-19 vaccine in people with HIV – a prospective observational cohort study

BACKGROUND: We investigated long-term durability of humoral and cellular immune responses to third dose of BNT162b2 in people with HIV (PWH) and controls. METHODS: In 378 PWH with undetectable viral replication and 224 matched controls vaccinated with three doses of BNT162b2, we measured IgG-antibod...

Descripción completa

Detalles Bibliográficos
Autores principales: Heftdal, Line Dam, Pérez-Alós, Laura, Hasselbalch, Rasmus Bo, Hansen, Cecilie Bo, Hamm, Sebastian Rask, Møller, Dina Leth, Pries-Heje, Mia, Fogh, Kamille, Gerstoft, Jan, Grønbæk, Kirsten, Ostrowski, Sisse Rye, Frikke-Schmidt, Ruth, Sørensen, Erik, Hilsted, Linda, Bundgaard, Henning, Garred, Peter, Iversen, Kasper, Sabin, Caroline, Nielsen, Susanne Dam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272831/
https://www.ncbi.nlm.nih.gov/pubmed/37331161
http://dx.doi.org/10.1016/j.ebiom.2023.104661

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272831/
https://www.ncbi.nlm.nih.gov/pubmed/37331161
http://dx.doi.org/10.1016/j.ebiom.2023.104661

Ejemplares similares